The AI Health Revolution: How Consumers Will Take Control in the Next Two Years
Sign up for our newsletter
On/Offcall is the weekly dose of information and inspiration that every physician needs.
As a physician, I've had patients email me copied-and-pasted outputs from AI chatbots like ChatGPT, seeking validation for self-diagnosed conditions or treatment ideas. It's a sign of the times: in 2026, consumer AI in health is already here, but it is not used widely and mostly in simple ways — for quick symptom checks or generic advice without deep personalization. Yet this is evolving fast. Imagine your smartwatch not just counting steps but predicting stress spikes or heart issues before they escalate. This isn't distant; it's the near future, unfolding in 2026–2027, where AI helps consumers shift from passive monitoring to proactive prevention.
In my book, Better Health With AI: Your Roadmap to Results, I share real stories like Sarah's, where her Apple Watch detected atrial fibrillation (AFib) early, averting a stroke. Today, such wearables are FDA-cleared to spot AFib, with research demonstrating that among participants notified of an irregular pulse, 84% had atrial fibrillation confirmed on simultaneous ECG recordings (Perez et al., 2019). Current consumer adoption is surging: approximately 91% of U.S. adults own a smartphone, which can measure heart rate, heart rate variability (HRV), respiratory rate, and blood oxygen levels (SpO₂) via their cameras and embedded sensors (Pew Research Center, 2025). Additionally, about 45% of U.S. consumers now own a smartwatch or fitness wearable, which in addition to the above can measure steps, distance, calories burned, sleep duration and quality, ECG (for AFib detection), skin temperature, stress levels, and continuous activity monitoring (Nagappan et al., 2024). But many consumers are unaware of the full extent of data being collected about them, and even fewer use it to its fullest potential — often because health data remains fragmented across siloed apps from different manufacturers, with limited seamless integration into a unified personal health dashboard.
Adoption won't explode like those old Breck shampoo ads, where one person tells two, who tell two more in viral fashion. Instead, it will roll out unevenly — driven by healthcare organizations and slowed by regulations, costs, and trust issues. Consumers will largely fall into four groups, each shaping the pace differently:
First, early adopters: tech-savvy individuals obsessed with longevity, like biohackers tracking every biomarker. They'll push boundaries, integrating advanced wearables and genetic data to optimize health spans, accelerating innovation through demand. Their successes — even something as simple as sustaining New Year's resolutions—will inspire others through shared stories.
Second, dabblers: the casual users who pose a quick question to an AI chatbot and bring the output to their doctor for discussion. It's low-commitment but builds familiarity, gradually normalizing AI as a supplement to professional care.
Third, the fearful: those paralyzed by privacy concerns, convinced their step count or heart rate data will instantly alert Big Brother. While valid worries exist about data breaches, these fears are often overstated; regulations like HIPAA and GDPR protect health information far better than many realize. Education and proven benefits will help this group warm up.
Fourth, the desperate: people with undiagnosed conditions or dire prognoses, turning to AI out of necessity. For them, tools offering second opinions or pattern detection in symptoms could be lifesavers. These remarkable successes — more common than occasional, as AI excels at uncovering insights physicians might overlook and even making rare breakthrough diagnoses — will spread widely and pull in skeptics.
Beyond these groups, institutional forces will nudge adoption along. Employers offering wellness programs with AI incentives, insurers providing discounts for monitored health — these make the tools feel either mandatory or rewarding, particularly for dabblers and the fearful. Meanwhile, passive integration through everyday tech — smartphone health features, smart home devices tracking vitals seamlessly — will draw in users without active effort, especially younger generations who view AI as default.
Over the next couple of years, we’ll see sharply increased utilization alongside meaningful technology breakthroughs. It will become commonplace for primary care doctors to review summarized step counts, active calories, diets tracked by simple photos before meals, pulses, HRV (heart rate variability), and sleep parameters. Patients will increasingly request or prefer AI-assisted reading of mammograms/other imaging and colonoscopies performed with AI-enhanced colonoscopes. Emerging technologies to analyze breath and sweat hold great promise for highly advanced health insights.
AI shines at data crunching but misses human nuances. It doesn't read personality, life goals, or facial expressions. Think of Dustin Hoffman in Rain Man playing blackjack. He counted cards perfectly but didn't read the room — didn't realize his flawless play would quickly garner the attention of casino security. AI can raise the same kind of red flags, too mechanical, lacking the subtle context a doctor provides. An overweight young woman grieving the recent loss of her mother isn't ready for diet and exercise instruction, despite what an algorithm might suggest.
By 2027, we'll see consumers using AI more frequently and in more ways regarding their health. They'll catch issues early, leading to better lives with less suffering. As I outline in my book, start integrating your data with AI now — the revolution is personal, and it's coming.
Sign up for our newsletter
On/Offcall is the weekly dose of information and inspiration that every physician needs.
References Perez, M. V., Mahaffey, K. W., Hedlin, H., Ruber, J. S., Dunn, J., Apple Heart Study Investigators, & Turakhia, M. P. (2019). Large-scale assessment of a smartwatch to identify atrial fibrillation. New England Journal of Medicine, 381(20), 1909–1917. https://doi.org/10.1056/NEJMoa1901183
Pew Research Center. (2025). Mobile fact sheet. https://www.pewresearch.org/internet/fact-sheet/mobile/
Nagappan, A., Krasniansky, A., & Knowles, M. (2024). Patterns of ownership and usage of wearable devices in the United States, 2020-2022: Survey study. Journal of Medical Internet Research, 26, e56504. https://doi.org/10.2196/56504
Sign up for our newsletter
On/Offcall is the weekly dose of information and inspiration that every physician needs.
Dr. Campazzi is a concierge doctor in Palm Beach, Florida. He is board certified and has trained and practiced at some of the finest medical institutions in the country. At the Mayo Clinic in Rochester, Minnesota, Dr. Campazzi spent several years on staff providing medical care and teaching resident physicians. He completed his medical training at The Johns Hopkins University and served as chief resident. He earned his medical doctorate from the University of Pittsburgh School of Medicine. Dr. Campazzi holds additional postgraduate degrees including a Master of Public Health with emphasis in Health Care Policy and Management and a Master of Health Sciences with emphasis in Immunology and Infectious Diseases, both from The Johns Hopkins University Bloomberg School of Public Health. In 2020, he completed The Stanford Genetics and Genomics Certificate program at Stanford University. Dr. Campazzi also earned his Master of Business Administration with Health Services Management concentration from Duke University Fuqua School of Business. He completed his Bachelor of Arts at The Johns Hopkins University.